RGEN Jun 2024 290.000 call
| Previous close | 0.3000 |
| Open | 0.3000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 290.00 |
| Expiry date | 2024-06-21 |
| Day's range | 0.3000 - 0.3000 |
| Contract range | N/A |
| Volume | |
| Open interest | 5 |
GuruFocus.comInsider Sell: CEO Anthony Hunt Sells 20,072 Shares of Repligen Corp (RGEN)
On May 21, 2024, Anthony Hunt, Chief Executive Officer of Repligen Corp (NASDAQ:RGEN), executed a sale of 20,072 shares of the company.
GlobeNewswireRepligen Corporation to Present at Upcoming June Investor Conferences
WALTHAM, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be presenting at the following June investor conferences. William Blair’s 44th Annual Growth Stock Conference being held in Chicago from June 4 – 6, 2024. Tony J. Hunt, Chief Executive Officer, is scheduled to present a company overview on June 5 at 12:00 p.m. CT.Jefferies’ Global Healthcare Conference being held
Insider MonkeyHere’s Why Baron Discovery Fund Sold Repligen Corporation (RGEN)
Baron Funds, an investment management company, released its “Baron Discovery Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. In the first quarter, the fund (Institutional Shares) returned 4.57% underperforming the 7.58% return for the Russell 2000 Growth Index. The firm is optimistic about the Fund’s prospects for 2024. […]
